Katja Weisel, MD Head of the Myeloma Center, University of Tubingen Discusses Anti-BCMA CAR-T Cell Therapy In MM. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Katja Weisel, MD Head of the Myeloma Center, University of Tubingen Discusses Anti-BCMA CAR-T Cell Therapy In MM. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com